Enovix Corp (ENVX) CLO acquires 58,500 performance-based share units

Rhea-AI Filing Summary

Enovix Corp Chief Legal Officer Arthi Chakravarthy reported an acquisition of common stock through the vesting of performance-based equity awards. On February 18, 2026, 36,174 performance restricted stock units (PRSUs) vested upon achievement of performance criteria, with 50% scheduled for release on April 1, 2027 and the remaining 50% on April 1, 2028.

On the same date, an additional 22,326 PRSUs vested, with 50% to be released on April 8, 2027 and 50% on April 8, 2028. Each PRSU represents a contingent right to receive one share of Enovix common stock upon settlement. Following these transactions, Chakravarthy directly owned 458,097 shares, including 262,360 shares issuable upon vesting and settlement of RSUs and previously vested PRSUs.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chakravarthy Arthi

(Last) (First) (Middle)

C/O ENOVIX CORPORATION

3501 W. WARREN AVENUE

(Street)

FREMONT CA 94538

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Enovix Corp [ ENVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/18/2026		A		36,174(1)	A	$0	435,771(2)	D
Common Stock	02/18/2026		A		22,326(3)	A	$0	458,097(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the vesting of 36,174 performance restricted stock units ("PRSUs") upon the achievement of certain performance criteria on February 18, 2026, of which 50% will be released on April 1, 2027 and the remaining 50% will be released on April 1, 2028. Each PRSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.

2. Includes 262,360 shares issuable upon the vesting and settlement of restricted stock units ("RSUs") granted to the Reporting Person, as well as the above referenced vested PRSUs and 10,393 vested PRSUs, which will be released on March 2, 2027. Each PRSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.

3. Represents the vesting of 22,326 PRSUs upon the achievement of certain performance criteria on February 18, 2026, 50% of which will be released on April 8, 2027, and the remaining 50% will be released on April 8, 2028. Each PRSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.

Remarks:

	/s/ Arthi Chakravarthy	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Enovix (ENVX) report for February 18, 2026?

Enovix reported that Chief Legal Officer Arthi Chakravarthy acquired common stock through the vesting of performance restricted stock units on February 18, 2026. The vesting reflected achievement of specified performance criteria and resulted in additional shares being scheduled for future release upon settlement.

How many Enovix (ENVX) shares did the Chief Legal Officer acquire in this Form 4?

The Chief Legal Officer acquired rights tied to 36,174 vested PRSUs and another 22,326 vested PRSUs on February 18, 2026. Each performance restricted stock unit represents a contingent right to receive one share of Enovix common stock when it is ultimately settled and released.

When will the vested Enovix (ENVX) PRSUs reported in this filing be released?

Of the 36,174 PRSUs that vested, 50% are scheduled for release on April 1, 2027 and 50% on April 1, 2028. For the 22,326 PRSUs, 50% are scheduled for release on April 8, 2027 and 50% on April 8, 2028.

What are performance restricted stock units (PRSUs) in the Enovix (ENVX) Form 4?

In this filing, PRSUs are equity awards that vest only after specified performance criteria are achieved. Each PRSU represents a contingent right to receive one share of Enovix common stock upon settlement, with actual share release occurring on scheduled future dates after vesting.

What is Arthi Chakravarthy’s Enovix (ENVX) share ownership after these transactions?

After the reported February 18, 2026 transactions, Chief Legal Officer Arthi Chakravarthy directly owned 458,097 Enovix shares. This amount includes 262,360 shares issuable upon the vesting and settlement of RSUs and vested PRSUs referenced in the detailed footnotes.

How do the RSUs and PRSUs affect Enovix (ENVX) share count for the reporting person?

The filing notes that holdings include 262,360 shares issuable from restricted stock units and vested PRSUs. These instruments increase Chakravarthy’s potential future share ownership as they vest and settle, each RSU or PRSU converting into one share of Enovix common stock.